Tyme Technologies Inc. (TYME)

[mcsharkey]

Apologies for this long over-due reply murocman. Got some great family events going on with our new grandson ANDDDDD couple other projects.

Going back to the CLINICAL TRIAL updates, for our Ewnings Sarcoma, check out the fields in this spreadsheet on the site. Primary Results should be released 31 October 2021. You can change the columns on the far right control box.

Last release was April 1st where our effort to date was "we passed futility", something like that. Really meaning we proved promising at that time. https://clinicaltrials.gov/ct2/results?term=SM-88&cond=Ewing+Sarcoma+AND+%22Ewing+Sarcoma%22.

In speaking with our IR rep
Jonathan Echardt TYME IR
[e-mail]
[phone]

is very helpful. Early in the board shake up, last June, he did indicate tackling advanced metastatic Pancreatic Cancer was a great target, and everybody was failing to achieve it. Hinted realignment back to breast cancer was probable. And so be it.

Thinking that the financing received then came with the caveat that the old board had to go.

New board has been more open in completely answering questions I've submitted. Got blown off a lot under the old tenure.

This is where we were on Breast Cancer project that lost funding a couple of years ago. https://people.com/health/head-of-the-class-khrystyne-haje-recovered-stage-iv-breast-cancer/

Alrighty Murocman, again my aplogies for over due response